Bassi, Pierfrancesco
 Distribuzione geografica
Continente #
EU - Europa 24.026
NA - Nord America 11.474
AS - Asia 7.545
SA - Sud America 1.375
AF - Africa 233
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 20
AN - Antartide 2
Totale 44.710
Nazione #
IT - Italia 14.897
US - Stati Uniti d'America 11.133
SG - Singapore 3.508
DE - Germania 2.790
CN - Cina 1.689
SE - Svezia 1.503
BR - Brasile 1.087
FR - Francia 1.024
NL - Olanda 916
UA - Ucraina 757
VN - Vietnam 625
GB - Regno Unito 503
IN - India 408
IE - Irlanda 358
PL - Polonia 340
ID - Indonesia 241
FI - Finlandia 208
RU - Federazione Russa 197
BD - Bangladesh 185
CA - Canada 185
JP - Giappone 170
HK - Hong Kong 147
AR - Argentina 111
TR - Turchia 109
CH - Svizzera 104
BE - Belgio 93
ES - Italia 86
IQ - Iraq 71
MX - Messico 71
ZA - Sudafrica 58
PK - Pakistan 47
EC - Ecuador 44
CI - Costa d'Avorio 41
MA - Marocco 37
AT - Austria 36
KR - Corea 35
CO - Colombia 34
VE - Venezuela 29
IR - Iran 27
JO - Giordania 27
RO - Romania 27
PH - Filippine 26
AL - Albania 25
AU - Australia 25
AZ - Azerbaigian 24
LT - Lituania 24
SA - Arabia Saudita 24
UZ - Uzbekistan 22
EG - Egitto 21
MY - Malesia 21
AE - Emirati Arabi Uniti 19
CL - Cile 19
NP - Nepal 16
PY - Paraguay 16
TN - Tunisia 15
HU - Ungheria 14
CZ - Repubblica Ceca 13
GR - Grecia 13
IL - Israele 13
PE - Perù 13
BZ - Belize 12
CR - Costa Rica 12
EU - Europa 12
PA - Panama 12
PT - Portogallo 12
TH - Thailandia 12
TW - Taiwan 12
DO - Repubblica Dominicana 11
KE - Kenya 11
UY - Uruguay 11
BO - Bolivia 10
DZ - Algeria 9
NG - Nigeria 9
RS - Serbia 9
JM - Giamaica 8
LB - Libano 8
LK - Sri Lanka 8
SN - Senegal 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
BH - Bahrain 7
ET - Etiopia 7
LV - Lettonia 7
BY - Bielorussia 6
DK - Danimarca 6
NZ - Nuova Zelanda 6
OM - Oman 6
A2 - ???statistics.table.value.countryCode.A2??? 5
HR - Croazia 5
IS - Islanda 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LU - Lussemburgo 5
MD - Moldavia 5
NI - Nicaragua 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
SM - San Marino 5
HN - Honduras 4
MM - Myanmar 4
Totale 44.630
Città #
Singapore 1.898
Chandler 1.631
Milan 1.445
Rome 1.310
Ashburn 1.224
San Jose 1.011
Jacksonville 427
Naples 422
Beijing 358
Dublin 347
San Mateo 333
Ann Arbor 318
Los Angeles 314
Florence 277
New York 253
Turin 251
Wilmington 247
Nanjing 242
Ho Chi Minh City 221
Jakarta 218
Warsaw 212
Bologna 208
Lauterbourg 202
Bari 180
Palermo 180
Houston 165
Munich 165
Hanoi 156
The Dalles 154
Dearborn 153
Frankfurt am Main 152
Woodbridge 146
Catania 139
Bremen 130
Boston 129
Hong Kong 128
Nanchang 128
Genoa 126
Nürnberg 125
São Paulo 122
Verona 121
Lawrence 115
Tokyo 113
Fairfield 107
Chicago 106
Dallas 105
Hefei 104
Moscow 98
Marseille 91
Cattolica 90
Redwood City 87
Seattle 86
Kraków 83
Princeton 79
Brussels 76
Brescia 73
Buffalo 70
Padova 66
Santa Clara 64
Helsinki 58
Lancaster 57
Mountain View 55
Venice 55
Cagliari 54
Paris 53
Falls Church 51
Ottawa 51
Toronto 51
Amsterdam 49
Council Bluffs 49
Parma 49
Taranto 47
Kunming 45
London 45
Izmir 44
Orem 44
Hyderabad 43
Pescara 43
Reggio Emilia 43
Boardman 42
Perugia 42
Redmond 42
Abidjan 41
Bergamo 41
Messina 41
Tianjin 41
Brooklyn 39
Montreal 39
Atlanta 37
Salerno 36
Cambridge 35
Livorno 35
Belo Horizonte 34
University Park 34
Hebei 33
Johannesburg 33
Düsseldorf 32
Haiphong 32
Augusta 31
Norwalk 31
Totale 19.338
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.124
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.231
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 956
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 920
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 612
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 431
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 420
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 359
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 328
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 325
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 318
Pros-IT CNR: an Italian prostate cancer monitoring project 282
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 276
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 264
Le infezioni delle vie urinarie 257
Metabolic reprogramming by malat1 depletion in prostate cancer 256
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 251
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 237
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 232
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 216
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 209
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 202
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 200
The occult urothelial cancer 200
Urological complications following inguinal hernioplasty 198
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 190
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 187
Evidenze microbiologiche in un singolo centro urologico 187
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 185
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 185
Male infertility: non-surgical therapy 181
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 176
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 174
Human factors in surgery: from Three Mile Island to the operating room 172
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 172
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 171
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 170
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 170
[Overactive bladder syndrome: the social and economic perspective] 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 169
Le complicanze nella chirurgia urologica 169
Size of Bladder Cancers: Correlation among Different Types of Measurement 168
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 168
Bladder and prostate metastasis from small cell lung cancer: a rare entity 168
Extracorporeal shockwave lithotripsy in pediatrics 167
Imaging in prostate cancer diagnosis: present role and future perspectives 167
Hot topics in urological health economics. A mini review 167
[Foreign bodies in urinary bladder: a clinical case] 165
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 165
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 163
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 163
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 163
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 163
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 163
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 162
Therapeutic strategies in penile cancer: state of the art 162
Antibiotic prophylaxis in urology 162
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 162
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 161
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 159
Microbiological follow-up of nosocomial infections in a single urological center 159
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 158
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 158
Brachytherapy in men with prostate cancer: update on indications and outcomes 157
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 157
Advanced bladder cancer: New agents and new approaches. A review 156
Imaging in prostate cancer staging: present role e future perspectives 156
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 156
Imaging of renal cell carcinoma: state of the art and recent advances 155
NBI: results review 154
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 153
Chirurgia robotica per tutti 152
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 151
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 151
Test F+10 SP: un nuovo metodo angioscintigrafico per la diagnosi dell'uropatia ostruttiva 149
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 149
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 149
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 148
[Innovative treatments of non muscle invasive bladder cancer] 148
Advanced bladder cancer: New agents and new approaches. A review 147
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 147
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 146
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 145
Imaging in prostate cancer staging: present role and future perspectives 145
Local relapse of prostate cancer after primary definitive treatment: the management 144
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 144
Circumcision: history, religion and law 142
Inhibition of prostate efferent neurotransmission by amikacin 142
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 142
Stone composition and vascular calcifications in patients with nephrolithiasis 141
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 140
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 140
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 140
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 140
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 139
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 138
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 137
InTrathecal mORphine, traNsversus Abdominis Plane Block, and tramaDOl Infusion for Catheter-Related Bladder Discomfort in Patients Undergoing Robot-Assisted Laparoscopic Prostatectomy (TORNADO): A Pilot Prospective Controlled Study 137
Totale 33.223
Categoria #
all - tutte 134.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 0 0 0 0 0 0 105
2021/20222.276 218 147 77 182 186 112 79 297 138 161 304 375
2022/20235.995 686 637 419 779 341 641 270 479 639 280 480 344
2023/20246.891 384 811 433 550 478 598 528 628 449 613 641 778
2024/20259.615 640 753 881 716 953 638 643 723 1.104 746 994 824
2025/202611.678 1.722 482 702 1.115 1.886 654 2.072 645 753 821 499 327
Totale 45.124